Risedronate Sodium
Risedronate Sodium is a bisphosphonate-derived calcium channel blocker that inhibits osteoclast-mediated bone resorption. It is widely used in osteoporosis research and has been validated in both in vitro cell-based assays and in vivo animal models for studying bone metabolism and mineral density.
Product Specifications
CAS Number
115436-72-1
Product Name Alternative
Risedronate, Risedronate Sodium, Risedronic Acid, Risedronic Acid Sodium, Inhibitor, HAP, Farnesyl pyrophosphate synthase, NE 58095 Sodium, inhibit
Field of Research
Cell Biology, Infectious Disease & Virology, Metabolism Research
Purity
98.30% (May vary between batches)
Solubility
DMSO:Insoluble; H2O:10 mM
Smiles
[Na+].OC (Cc1cccnc1) (P (O) (O) =O) P (O) ([O-]) =O
Molecular Formula
C7H10NNaO7P2
Molecular Weight
305.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
360841-01 50 µL
NAT10 (N-Acetyltransferase 10, ALP, KIAA1709) discontinued
Sign In for Pricing
View Details 360841-02 100 µL
NAT10 (N-Acetyltransferase 10, ALP, KIAA1709) discontinued
Sign In for Pricing
View Details